Gray Matter Analytics
Less Intuition...More Evidence
Published Sep 30, 2026
The vendor’s public pages reference continued investment in AI capabilities, but specific deliverables, timelines, and product roadmap details were not provided in publicly accessible materials.
Searches conducted as part of this report did not locate a credible G2 or Capterra product listing for Gray Matter Analytics or CoreTechs. Possible explanations include: no listing exists, a listing exists under a different name, or the listing was not indexed in the search results used for this report.
Searches did not locate discussions of Gray Matter Analytics or CoreTechs on Reddit or Hacker News within the indexed sources used for this report. For enterprise healthcare platforms, this is not unusual, but it reduces visibility into independent user sentiment.
A third-party review page with strongly negative narrative alleging slow delivery and outdated documentation was identified; the source appears to be low-signal and unverified for enterprise procurement decisions. Treat such sources with caution.
Balanced takeaway: Public evidence is primarily vendor-published success quotes and press releases; independent review coverage and standardized user reviews are limited.
GMA announced a partnership supporting clinical, operational, and financial performance, including analytics for medication management, chronic disease, follow-up care, and VBC contract tracking.
Vendor-published statements from a regional payer and a large health system emphasize analytics support and development acceleration.
GMA targets organizations that participate in or manage risk-based contracts and government programs (Medicaid/Medicare), particularly where quality reporting and performance incentives/penalties affect revenue. Typical targets include:
Get a comprehensive analysis of Gray Matter Analytics including market position, competitive landscape, adoption trends, and peer benchmarks.
Download full report →The vendor’s public site includes customer quotes attributed to named organizations. Representative examples include quotes from:
These vendor-published comments indicate that customers value:
GMA announced that a state Medicaid agency implemented its analytics solution following a pilot. The vendor statement indicates the pilot identified opportunities for improvement and supported targeting members for care management with more timely data and transparency.
Gray Matter Analytics (GMA) is a healthcare analytics vendor focused on value-based care (VBC) contract performance management for state Medicaid agencies, payors, and providers. Its primary product suite, CoreTechs, is delivered as a cloud-hosted analytics service that aggregates disparate healthcare data (claims, EMR/EHR, HIE, socio-demographic/SDoH, etc.) and provides analytics for:
GMA describes an AI/ML component, "GMA Genius", intended to predict measure compliance and inform intervention prioritization (for example, interventions that consider health equity). These capabilities are presented in vendor materials; limited third-party validation was found in publicly available sources.